SGLT2 inhibitors in patients with type 2 diabetes and renal disease: overview of current evidence.
Postgrad Med. 2019 May;131(4):251-260. doi: 10.1080/00325481.2019.1601404. Epub 2019 Apr 14.
Postgrad Med. 2019.
PMID: 30929540
Review.